An editorial in the journal said the FDA’s process of using existing devices as the basis for evaluating safety and effectiveness of a new device is “untenable” and should be stopped immediately for Class III devices.
Answering device industry concerns that a more extensive review would be a burden, the journal noted ongoing lawsuits on metal-on-metal hip implants that could cost Depuy Orthopaedics up to $1 billion.
Read the Mass Device report on overhauling the FDA’s medical device approval process.
Related Articles on the FDA Medical Device Approval Process:
FDA Clarifies Device Approval Process
FDA Seeking Comment on IOM Device Recommendations
FDA Proposes Updating Device Reviews, Including for Joints, IOLs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.